Clinical Trials Logo

Clinical Trial Summary

This intervention study investigates the effects of various kale preparations (dietary supplements) on lipid status parameters. Within the study period of 8 weeks, three blood withdrawals are planned (week 0, 4 and 8) for the volunteers. Lipid status parameters (total cholesterol, HDL cholesterol, LDL cholesterol, triacylglycerides) will be determined in blood. There is a correlation between contents of LDL cholesterol, total cholesterol and triacylglycerides and the risk for cardiovascular diseases (CVD). In contrast, a high content of HDL cholesterol is correlated with a lower risk for CVD. In addition, the contents of apolipoprotein A1 and apolipoprotein B will be analysed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Effects of Kale Ingredients on Lipid Status Parameter

NCT number NCT03545555
Study type Interventional
Source University of Jena
Contact Volker Böhm, PD Dr.
Phone +49-(0)3641-9496
Email Volker.Boehm@uni-jena.de
Status Recruiting
Phase N/A
Start date April 13, 2018
Completion date December 2020